4-amino substituted-6-aryl/heteroaryl substituted-2-methylsulfanyl-pyrimidine-5-carbaldehyde intermediates
US7314934B2 · kind B2 · utility
4Cited by
16References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2003 |
| Grant date | Jan 1, 2008 |
| Priority date | — |
| Expiry date | Jul 27, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.